Skip to main content
Livermore
Livermore
ZHEN

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

Q1 2025 vs. Q4 2024

How the institutions holding Immunovant, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of IMVT: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders1872194+9
Shares80.1M915.2K94.8M+15.5M (+19.6%)
Value$1.98B$22.7M$1.62B−$342.0M (−17.4%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held Immunovant, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to IMVT in Q1 2025
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.801,927$13.7M0.04%
Great Point Partners LLC375,000$6.41M3.48%
Nuveen, LLC233,985$4.00M0.00%
Sphera Funds Management Ltd.194,638$3.33M0.82%
Marshall Wace, LLP138,477$2.37M0.00%
Polygon Management Ltd.131,167$2.24M0.72%
HighVista Strategies LLC95,648$1.63M0.63%
Privium Fund Management B.V.72,000$1.23M0.32%
Cubist Systematic Strategies, LLC58,122$993.3K0.01%
Tejara Capital Ltd53,790$919.3K0.45%
Omers Administration Corp48,300$825.4K0.01%
Bridgefront Capital, LLC36,059$616.2K0.18%
Quinn Opportunity Partners LLC35,100$599.9K0.04%
Dark Forest Capital Management LP31,726$542.2K0.02%
Quadrature Capital Ltd14,498$247.8K0.01%
Fox Run Management, L.L.C.13,428$229.5K0.04%
CIBC World Markets Corp12,880$220.1K0.00%
Axq Capital, LP11,453$195.7K0.08%
Fieldview Capital Management, LLC10,779$184.2K0.03%
SIH Partners, LLLP10,705$182.9K0.02%
Squarepoint Ops LLC10,425$178.2K0.00%
Virtus Investment Advisers, Inc.5,953$101.7K0.03%
Point72 Hong Kong Ltd4,416$75.5K0.01%
Point72 (DIFC) Ltd3,923$67.0K0.01%
Headlands Technologies LLC2,961$50.6K0.01%
BI Asset Management Fondsmaeglerselskab A/S2,181$37.0K0.00%
FNY Investment Advisers, LLC2,000$34.0K0.02%
Quadrant Capital Group LLC515$8.80K0.00%
Massmutual Trust Co FSB168$2.87K0.00%
Huntington National Bank158$2.70K0.00%
Private Wealth Management Group, LLC106$1.81K0.00%
Sierra Ocean, LLC97$1.66K0.00%
Coldstream Capital Management Inc33$5640.00%
True Wealth Design, LLC32$5470.00%
South State Corp.24$4110.00%
Stephens Consulting, LLC20$3420.00%

Sold out (27)

Institutions that held Immunovant, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of IMVT in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Franklin Resources Inc984,063$24.4M
Boxer Capital Management, LLC825,000$20.4M
RTW Investments, LP530,614$13.1M
Emerald Mutual Fund Advisers Trust156,097$3.87M
AXA S.A.98,683$2.44M
Simplex Trading, LLC86,847$2.15M
Caption Management, LLC86,760$2.15M
OrbiMed Advisors LLC78,500$1.94M
Victory Capital Management Inc45,100$1.12M
Occudo Quantitative Strategies LP34,731$860.3K
HSBC Holdings PLC31,896$780.2K
XTX Topco Ltd22,740$563.3K
F/M Investments LLC20,573$509.6K
Two Sigma Advisers, LP10,900$270.0K
Aigen Investment Management, LP10,898$269.9K
Jain Global LLC10,111$250.4K
Ameriprise Financial Inc8,907$220.6K
Pictet & Cie (Europe) SA8,089$200.4K
Virtus ETF Advisers LLC2,577$63.8K
Ikarian Capital, LLC600$14.9K
R Squared Ltd570$14.1K
BFSG, LLC565$14.0K
Aster Capital Management (DIFC) Ltd190$4.71K
Ci Investments Inc.106$3.00K
Comerica Bank96$2.38K
Bessemer Group Inc50$1.00K
Bryn Mawr Trust Co24$594

Not filed for Q1 2025 yet (2)

Institutions that held Immunovant, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMVT in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC915,151$22.7M
Cassady Schiller Wealth Management, LLC2$50